Tenaya Therapeutics *

Tenaya Therapeutics is a clinical-stage biotechnology company headquartered in South San Francisco, California, focused on discovering, designing, developing, and delivering potentially curative gene therapies and precision medicines that address the underlying drivers of heart disease. Its clinical pipeline includes TN-201, an AAV-based gene therapy for MYBPC3-associated hypertrophic cardiomyopathy (HCM), and TN-401 for PKP2-associated arrhythmogenic right ventricular cardiomyopathy (ARVC), both in early clinical development. Publicly traded on Nasdaq as TNYA and backed by investors including GV, the company operates as a therapeutics developer and publishes no public developer platform or API surface.

Tenaya Therapeutics * is profiled on the APIs.io network. Tagged areas include Company, Life Sciences, Biotechnology, Gene Therapy, and Cardiovascular.

Tenaya Therapeutics *’s developer surface includes engineering blog, support, and 4 more developer resources.

🌐 Visit website 📡 Source on GitHub

15.0/100 emerging ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-07-27 · rubric v0.5

0 APIs

CompanyLife SciencesBiotechnologyGene TherapyCardiovascularPrecision MedicineClinical Stage

Kin Score

Kin Score How this is scored →
scored 2026-07-27 · rubric v0.5

Composite quality — 15.0/100 · emerging

Contract Quality 0.0 / 25

Developer Ergonomics 1.3 / 20

Commercial Clarity 4.2 / 20

Operational Transparency 0.0 / 13

Governance 0.0 / 12

Discoverability 6.8 / 10

Agent readiness — 0/100 · human only

Machine-Readable Contract 0 / 18

Agentic Access Contract 0 / 15

MCP Server 0 / 12

Machine-Readable Auth 0 / 10

Idempotency 0 / 9

Stable Error Semantics 0 / 8

Request/Response Examples 0 / 7

Rate-Limit Signaling 0 / 7

Typed Event Surface 0 / 6

Agent Skills 0 / 5

Well-Known Catalog 0 / 4

Consent & Bot Identity 0 / 3

Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/tenaya-therapeutics: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Access & Security 1

Authentication, authorization, and security posture

DomainSecurity

DomainSecurity

Operate 1

Status, limits, changes, and where to get help

Support

Support

Commercial 2

Pricing, plans, and the legal terms of use

PrivacyPolicy

PrivacyPolicy

TermsOfService

TermsOfService

Company 2

The organization behind the API

Website

Website

Blog

Blog

Source (apis.yml)

aid: tenaya-therapeutics
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/tenaya-therapeutics.png
name: Tenaya Therapeutics *
description: Tenaya Therapeutics is a clinical-stage biotechnology company headquartered in South San Francisco, California,
  focused on discovering, designing, developing, and delivering potentially curative gene therapies and precision medicines
  that address the underlying drivers of heart disease. Its clinical pipeline includes TN-201, an AAV-based gene therapy for
  MYBPC3-associated hypertrophic cardiomyopathy (HCM), and TN-401 for PKP2-associated arrhythmogenic right ventricular cardiomyopathy
  (ARVC), both in early clinical development. Publicly traded on Nasdaq as TNYA and backed by investors including GV, the
  company operates as a therapeutics developer and publishes no public developer platform or API surface.
url: https://raw.githubusercontent.com/api-evangelist/tenaya-therapeutics/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- gv
x-tier: stub
x-tier-reason: portfolio-lead
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-21'
tags:
- Company
- Life Sciences
- Biotechnology
- Gene Therapy
- Cardiovascular
- Precision Medicine
- Clinical Stage
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: Website
  url: https://www.tenayatherapeutics.com
- type: Blog
  url: https://investors.tenayatherapeutics.com/news-events/news-releases
- type: Support
  url: https://www.tenayatherapeutics.com/contact-us/
- type: PrivacyPolicy
  url: https://www.tenayatherapeutics.com/privacy-policy/
- type: TermsOfService
  url: https://www.tenayatherapeutics.com/terms-of-use
- type: DomainSecurity
  url: security/tenaya-therapeutics-domain-security.yml
x-enrichment:
  date: '2026-07-21'
  status: minimal
  artifacts_added: 1
  pass: local-v1